Home > Insider Trading > Filing (0001127602-22-005441)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201184	Lourdes Weltzien	3471 River Hills Drive Cincinnati OH 45244	Evp, Life Science	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-15	12,500	$14.65	95,548	No	4	M	Direct
Common Stock	Acquisiton	2022-02-15	7,500	$14.30	103,048	No	4	M	Direct
Common Stock	Disposition	2022-02-15	20,000	$25.60	83,048	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2022-02-15	12,500	$0.00	12,500	$14.65
Common Stock	Stock Options (Right to Buy)	Disposition	2022-02-15	7,500	$0.00	7,500	$14.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-11-08	No	4	M	Direct
2,500		2028-04-24	No	4	M	Direct

Footnotes

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $25.29 to $26.07. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
These non-qualified options were awarded under the 2012 Stock Incentive Plan and cliff vested in full on November 15, 2021.
These options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on April 24, 2022.